H.R. 846 makes it unlawful for any person to place advertising that misrepresents the reproductive health services they provide—specifically, claims that they offer abortion or contraception (or referrals for those services) or that they employ or provide access to licensed medical personnel. The Federal Trade Commission (FTC) must issue regulations under the Administrative Procedure Act and enforces violations as unfair or deceptive acts under the FTC Act.
The bill expands the FTC’s enforcement reach to include organizations not traditionally within the Commission’s jurisdiction (including nonprofits), gives the FTC independent litigation authority, and authorizes civil penalties equal to the greater of $100,000 (inflation‑adjusted) or 50 percent of the ultimate parent entity’s revenue in the prior 12 months. It also requires periodic reporting to Congress.
Compliance officers at health providers, nonprofit legal teams, and digital advertisers should expect immediate operational and legal consequences if the bill becomes law.
At a Glance
What It Does
The bill outlaws advertising that falsely claims a person offers abortion or contraception services or referrals, or that the person employs or provides access to licensed medical staff. It directs the FTC to write implementing regulations under 5 U.S.C. §553 and treats violations as unfair or deceptive acts under the FTC Act.
Who It Affects
The rule applies to any advertiser described as a 'person' under 5 U.S.C. §551—including crisis pregnancy centers, clinics, telehealth vendors, and nonprofits—and reaches the advertising and promotional channels they use, such as websites, signage, and digital ads. Platforms and intermediaries that publish or host such ads should monitor claims but the statute targets the advertiser.
Why It Matters
This is a narrowly focused federal consumer‑protection intervention aimed at misleading reproductive‑health advertising, but with broad procedural consequences: the FTC gains explicit rulemaking and civil‑litigation authority, including over nonprofits, and a high, revenue‑tied penalty that raises the practical stakes for compliance.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
At its core, H.R. 846 creates a federal prohibition on deceptive advertising about reproductive‑health services. The prohibited conduct is concrete: advertising that misrepresents that the advertiser provides contraception, abortion, referrals for those services, or access to licensed medical personnel.
The text defines abortion services broadly to include any medical or non‑medical service related to abortion, so messages about counseling, appointments, or referrals can fall within the rule if they are misleading.
The bill tasks the Federal Trade Commission with filling in specifics by issuing regulations under the Administrative Procedure Act (the same rulemaking process agencies use for significant regulatory programs). After the FTC issues regulations, any violation is treated as an unfair or deceptive act under the FTC Act, meaning the Commission can use its established investigatory tools, administrative and civil litigation pathways, and remedies developed in consumer‑protection practice.A notable change is the statutory waiver of certain jurisdictional limitations so the FTC may pursue organizations not organized for profit.
The Commission gets independent civil‑action authority to seek injunctions, civil penalties, restitution for consumers, and other equitable relief in federal court; the FTC also retains primary control over initiating and supervising such litigation. Penalties are calibrated either as a fixed floor adjusted for inflation or as a function of corporate scale—50 percent of the ultimate parent’s revenue for the preceding 12 months—making violations potentially very costly.Practically, covered organizations will need to audit public‑facing claims: website language, ad copy, signage, and intake scripts; document the credentials and availability of licensed medical staff they reference; and adopt policies for accurate referral practices.
Even faith‑based or nonprofit entities that historically relied on different regulatory expectations must consider compliance because the bill explicitly brings nonprofits within the FTC’s enforcement reach. The FTC also must report to Congress beginning one year after enactment and every two years thereafter on its enforcement actions and rulemaking under the statute.
The Five Things You Need to Know
The statute makes it unlawful to advertise that an entity offers contraception or abortion services (or referrals for them) or that it employs or offers access to licensed medical personnel.
The FTC must promulgate implementing regulations under the APA (5 U.S.C. §553) before or while enforcing the prohibition.
Violations are treated as unfair or deceptive acts under Section 18(a)(1)(B) of the FTC Act, enabling the FTC to use its full investigatory and enforcement toolkit.
The bill waives certain FTC jurisdictional limits to permit enforcement against organizations not organized for profit, explicitly bringing many nonprofits into the Commission’s scope.
Civil penalties may not exceed the greater of $100,000 (inflation‑adjusted) or 50 percent of the ultimate parent entity’s revenue in the prior 12 months; the FTC also may seek injunctions, restitution, and damages.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Short title
Declares the Act’s popular names: the 'Stop Antiabortion Disinformation Act' and the 'SAD Act.' This is purely caption language but signals legislative intent to target deceptive anti‑abortion advertising practices.
Findings supporting the policy
Sets out the Committee’s factual predicates: increases in clinic closures and travel burdens after Dobbs, the prevalence of crisis pregnancy centers (CPCs) relative to clinics, and alleged deceptive practices by CPCs, including false claims about medical staffing and privacy. These findings frame enforcement priorities and provide context that courts and the FTC may consult when interpreting ambiguous statutory terms.
Substantive prohibition on deceptive advertising
Defines the prohibited conduct with two discrete prongs: (1) advertising that misrepresents offering abortion or contraception (or referrals); and (2) advertising that misrepresents employing or providing access to licensed medical personnel. The clause is medium‑neutral—applying to any 'advertising'—so print, web, social, signage, and scripted intake communications are within scope. The statutory language focuses on misrepresentation, leaving the FTC to specify how to prove deception in rulemaking and enforcement.
FTC rulemaking and enforcement powers (including nonprofits)
Directs the FTC to issue regulations under the APA (section 553) and treats a breach as an unfair or deceptive act under the FTC Act. The statute expressly extends the FTC’s enforcement authority to organizations not organized for profit by overriding certain jurisdictional provisions, and it authorizes the Commission to use its full array of powers, including investigations, administrative proceedings, and civil litigation in federal court.
Independent civil‑action authority and litigation control
Grants the FTC express authority to bring civil actions in federal court for injunctions, penalties, restitution, and other equitable relief, and designates the Commission as the primary litigant (with limited Attorney General involvement). Practically, that centralizes enforcement decisions within the FTC and allows the Commission to seek traditional court remedies rather than relying solely on administrative adjudication.
Penalties, reporting, savings clause, and definitions
Imposes a two‑part penalty ceiling: the greater of $100,000 (adjusted for inflation) or 50 percent of the ultimate parent entity’s revenue in the prior 12 months. Requires the FTC to report to Congress starting one year after enactment and then every two years about enforcement and regulations adopted. Includes a savings clause preserving other FTC authorities and defines key terms—'abortion services,' 'Commission' (FTC), and 'person' by reference to 5 U.S.C. §551(2)—which broadens reach and clarifies core vocabulary.
This bill is one of many.
Codify tracks hundreds of bills on Healthcare across all five countries.
Explore Healthcare in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Patients and pregnant people (especially in underserved and low‑income communities): By targeting deceptive claims that can delay or deter access to time‑sensitive abortion and contraception services, the bill aims to make informational pathways to legitimate providers clearer.
- Licensed reproductive‑health providers and clinics: Reducing misleading local advertising from centers that falsely present themselves as full clinical providers can lower patient diversion and intake confusion, improving referral quality and operational efficiency.
- Consumer‑protection advocates and state regulators: The statute provides a clear federal standard and an empowered federal enforcer, creating a tool for addressing deceptive local advertising that may have been harder to challenge under state law alone.
Who Bears the Cost
- Crisis pregnancy centers and similarly positioned nonprofit organizations: The bill explicitly brings nonprofits within FTC enforcement scope, exposing them to investigations, civil litigation, and substantial penalties if their advertising falls within the prohibition.
- Small faith‑based or community organizations that advertise reproductive services informally: Organizations that lack compliance programs risk costly litigation and may need to invest in legal review, staffing, and training to avoid inadvertent violations.
- Advertisers and marketing vendors, including telehealth providers: Entities that place or write copy must tighten review processes, preserve evidence supporting claims and referrals, and potentially alter how they represent staffing and referral networks, increasing compliance and operational costs.
- Digital platforms and intermediaries (operationally): While the statute targets the advertiser, platforms may face higher takedown volumes, increased notice‑and‑response burdens, and reputational pressure to police content, creating indirect costs.
- The FTC (administratively): Expanded jurisdiction, rulemaking duties, and mandated reporting imply resource demands; the agency will need to prioritize staffing and investigatory capacity to implement and defend the program.
Key Issues
The Core Tension
The central trade‑off is between protecting consumers from deceptive, time‑sensitive misinformation about reproductive care and avoiding an overbroad enforcement regime that chills lawful speech (including religious or political messaging), punishes small or mission‑driven nonprofits disproportionately, or imposes heavy administrative burdens on intermediaries and the FTC itself.
The bill leaves important implementation questions to FTC rulemaking and litigation. 'Advertising' and 'misrepresentation' are legal concepts that depend on context—consumer expectation, materiality, and deception tests under the FTC Act—so the Commission’s rulemaking will determine how broadly online posts, intake scripts, and third‑party directories are covered. The statute’s medium‑neutral language means courts and the FTC must decide whether passively hosted content or third‑party listings qualify as advertiser conduct or merely platform speech.
Including nonprofits removes a historical enforcement boundary, but it raises proportionality and constitutional risks. The 50 percent revenue penalty tied to an ultimate parent’s prior 12‑month revenue could produce severe, sometimes crippling fines and will likely prompt litigation over statutory interpretation (who counts as 'ultimate parent') and fairness.
Finally, the bill does not create a safe harbor for platforms or intermediaries that merely host ads, so the practical burden of policing and responding to complaints may fall in part on private firms, increasing operational complexity without clear statutory guidance on intermediary liability or notice procedures.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.